Alnylam Pharmaceuticals Inc (XTER:DUL)
€ 278 -17.1 (-5.79%) Market Cap: 33.77 Bil Enterprise Value: 32.25 Bil PE Ratio: 78.70 PB Ratio: 35.74 GF Score: 74/100

Alnylam Pharmaceuticals Inc at Ginkgo Bioworks Ferment Conference Transcript

Apr 19, 2023 / 07:50 PM GMT
Release Date Price: €227.2


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALNY.OQ - Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc at Ginkgo Bioworks Ferment Conference
Apr 19, 2023 / 07:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Analyst, [1]
--------------------------------------------------------------------------------
John, thanks for being here with me today to chat about your success in Alnylam.

--------------------------------------------------------------------------------
Unidentified Company Representative, [2]
--------------------------------------------------------------------------------
Thank you, Jen. I do want to start by saying if Ginkgo can make it easier, I would love that because it wasn't easy to what we did. So it's an opportunity, for sure.

=====================
Questions and Answers
--------------------------------------------------------------------------------
Unidentified Analyst, [1]
--------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot